Skip to content
GLP-1 Savers
Cheapest GLP-1

Research & guides

The Medicare GLP-1 Bridge Program: What It Actually Covers in 2026

Eligible Medicare Part D members pay $50 through the GLP-1 Bridge. Check the drugs, BMI thresholds, exclusions and costs outside the Part D benefit.

By Grant Ashford, Founder & Pricing Editor
What's in this guide

The Medicare GLP-1 Bridge offers eligible Part D beneficiaries certain weight-management drugs for a $50 monthly copay. It runs July 1, 2026 through December 31, 2027 and operates outside the standard Part D benefit1. Check the eligibility rules before comparing this price with a cash program.

Which drugs and devices are included?

Medicare's patient page lists Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen. Single-dose Zepbound pens and vials are excluded2. Ozempic and Mounjaro are not on that list. A prescription for the same active ingredient does not make every brand or device eligible.

Who qualifies?

You need eligible Medicare drug coverage and must be at least 18. CMS sets three routes, using BMI at the start of GLP-1 therapy3:

Starting BMIOther criteria
35 or higherNone required for this BMI route
30 or higherHeart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or higher
27 or higherPrediabetes, previous heart attack or stroke, or symptomatic peripheral artery disease

CMS defines uncontrolled hypertension here as blood pressure above 140 systolic or 90 diastolic despite two concurrent blood-pressure medicines. Your prescriber must document the applicable criteria and ongoing nutrition and physical activity support3. These are coverage criteria, not a recommendation to change treatment or body weight to qualify.

When your regular Part D plan is the right place to check

Medicare's patient guidance excludes people already receiving GLP-1 coverage through their Part D plan and directs people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease toward their plan's coverage2. A Bridge exclusion does not mean all GLP-1 coverage is unavailable. Ask your prescriber and plan to check the actual drug and indication before paying cash.

What the $50 does and does not pay for

The $50 is the Bridge drug copay. The Part D deductible does not apply, but the copay does not count toward Part D's out-of-pocket spending threshold. Low-Income Subsidy assistance does not reduce this Bridge copay1. Budget separately for any appointment or program charges; a low pharmacy charge does not establish the cost of a prescriber's services.

How to get a coverage decision

Ask your prescriber to check the official criteria and submit the prescription and required authorization. Medicare says approved authorization can cover refills and dose changes through December 31, 2027, unless you switch GLP-1 drugs2. Ask the pharmacy to confirm approval and your charge before you commit to a separate cash plan. Keep the approval letter with your medication records.

Medicaid BALANCE is a different program

CMS's voluntary BALANCE model allows Medicaid agencies to join between May 2026 and January 1, 2027. Actual coverage depends on state and manufacturer participation and patient eligibility; it is not a nationwide Medicaid benefit4. Our Medicaid GLP-1 coverage guide shows how current state rules differ.

CMS extended the Medicare Bridge through 2027 while BALANCE is not launching in Part D in 20271. Do not assume a future Medicare BALANCE start date from an older announcement.

Compare the covered route before paying cash

The useful comparison is your approved pharmacy charge plus any care fees against a written ongoing cash quote for the same supply. Our Zepbound insurance guide explains plan approval versus manufacturer discounts, and Zepbound self-pay costs explains the dose and refill conditions. Commercial savings cards generally exclude Medicare enrollees; see the savings-card guide before counting on one.

Frequently asked questions

What does the Medicare GLP-1 Bridge cover?

Eligible beneficiaries can access Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen for a $50 monthly copay. The temporary program runs July 1, 2026 through December 31, 2027 outside the standard Part D benefit.

Does everyone with Medicare qualify?

No. Eligible Part D coverage, age, BMI and other program requirements apply. The BMI 35-or-higher route does not require an additional qualifying condition, while lower thresholds do. Ordinary Part D coverage for another indication must be checked separately.

Does the $50 count toward my Part D out-of-pocket limit?

No. CMS says the Bridge copay does not count toward Part D out-of-pocket spending, and Low-Income Subsidy assistance does not reduce it.

Is the Bridge the same as Medicaid BALANCE?

No. The Bridge serves eligible Medicare beneficiaries; Medicaid BALANCE depends on voluntary state and manufacturer participation. The Medicare Bridge is extended through 2027 while BALANCE is not launching in Part D in 2027.

References

  1. Centers for Medicare & Medicaid Services (2026). Medicare GLP-1 Bridge. CMS.gov. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
  2. Centers for Medicare & Medicaid Services (2026). Weight loss drugs. Medicare.gov. https://www.medicare.gov/coverage/weight-loss-drugs
  3. Centers for Medicare & Medicaid Services (2026). Information for Part D Plans. CMS.gov. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-part-d-plans
  4. Centers for Medicare & Medicaid Services (2026). BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model. CMS.gov. https://www.cms.gov/priorities/innovation/innovation-models/balance

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Keep reading